Skip to content

Levonordefrin

Carbocaine W/ Neo-cobefrin (levonordefrin) is a small molecule pharmaceutical. Levonordefrin was first approved as Carbocaine W/ Neo-cobefrin on 1982-01-01. It is used to treat oral ulcer and toothache in the USA. It is known to target alpha-1D adrenergic receptor.
Trade Name Carbocaine W/ Neo-cobefrin
Common Name Levonordefrin
Indication oral ulcer, toothache
Drug Class
Levonordefrin
Get full access now